1 |
Kawecki D, Pacholczyk M, Lagiewska B, et al. Bacterial and fungal infections in the early post-transplantation period after liver transplantation: etiologic agents and their susceptibility[J]. Transplant Proc, 2014,46(8): 2777-2781.
|
2 |
林宗钦,江智毅,陈娟,等. 重症患者万古霉素血清谷浓度监测的临床研究[J]. 中华危重病急救医学,2014,26(7): 473-477.
|
3 |
Zonozi R, Wu A, Shin JI, et al. Elevated vancomycin trough levels in a tertiary health system: frequency, risk factors, and prognosis[J]. Mayo Clin Proc, 2019,94(1):17-26.
|
4 |
张弋,吴瑛,沈中阳. 万古霉素在我院肝移植患者中的治疗药物监测及临床应用分析[J]. 中国药房,2011,22(26):2451-2453.
|
5 |
罗姣,白源,李晓云,等. 万古霉素血清谷浓度监测在终末期肝病患者肝移植术后的应用及临床意义[J]. 中国疗养医学,2019,28(9):981-982.
|
6 |
Ye ZK, Chen YL, Chen K, et al. Therapeutic drug monitoring of vancomycin: a guideline of the Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society[J]. J Antimicrob Chemother, 2016,71(11):3020-3025.
|
7 |
Zelenitsky S, Rubinstein E, Ariano R, et al. Vancomycin pharmacodynamics and survival in patients with methicillin-resistant Staphylococcus aureus-associated septic shock[J]. Int J Antimicrob Agents, 2013,41(3):255-260.
|
8 |
Cardile AP, Tan C, Lustik MB, et al. Optimization of time to initial vancomycin target trough improves clinical outcomes[J]. Springerplus, 2015,4:364.
|
9 |
何娟,杨婉花. 基于群体药动学的万古霉素个体化给药模式的建立和临床应用[J]. 中国临床药学杂志,2015,24(1):27-31.
|
10 |
陆灏迪,唐莲,薛盛敏,等. 万古霉素群体药代动力学在肾功能亢进患者中的临床验证[J]. 中华危重病急救医学,2018,30(5): 444-448.
|
11 |
林良沫,符祥俊,陈君,等. 个体化给药辅助决策系统JPKD和SmartDose在万古霉素个体化给药中的应用[J]. 中国药房,2019,30(19):2690-2695.
|
12 |
薛盛敏,陆灏迪,唐莲,等. 群体药代动力学软件对万古霉素稳态谷浓度的预测能力分析[J]. 中华危重病急救医学,2020, 32(1): 5055.
|
13 |
Chueiri Neto F, Emidio LA, Perales SR, et al. Bloodstream infections in early postsurgery liver transplant: an analysis of 401 patients over 10 years[J]. Transplant Proc, 2019,51(6):1972-1977.
|
14 |
Gyamlani G, Potukuchi PK, Thomas F, et al. Vancomycin-associated acute kidney injury in a large veteran population[J]. Am J Nephrol, 2019,49(2):133-142.
|
15 |
Durand F, Francoz C, Asrani SK, et al. Acute kidney injury after liver transplantation[J]. Transplantation, 2018,102(10):1636-1649.
|
16 |
Thongprayoon C, Kaewput W, Thamcharoen N, et al. Incidence and impact of acute kidney injury after liver transplantation: a meta-analysis[J]. J Clin Med, 2019,8(3):372.
|
17 |
Chen X, Ding X, Shen B, et al. Incidence and outcomes of acute kidney injury in patients with hepatocellular carcinoma after liver transplantation[J]. J Cancer Res Clin Oncol, 2017,143(7):1337-1346.
|
18 |
Marti R, Rosell M, Pou L, et al. Influence of biochemical parameters of liver function on vancomycin pharmacokinetics[J]. Pharmacol Toxicol, 1996,79(2):55-59.
|
19 |
魏思东,陈国勇,孙建军,等. 直接胆红素和总胆红素比值在肝移植术后并发症鉴别诊断中的作用[J]. 中国实用医刊,2014,41(20):1-6.
|
20 |
Delanaye P, Cavalier E, Pottel H. Serum creatinine: Not so simple![J]. Nephron, 2017, 136(4):302-308.
|
21 |
Rybak MJ, Le J, Lodise TP, et al. Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists[J]. Am J Health Syst Pharm, 2020,77(11): 835-864.
|